Increased Uptake of Technetium-99m-Hexamethylpropyleneamine Oxime Related to Primary Leptomeningeal Melanoma

References

1. ↵
   Allcutt D, Michowiz S, Weitzman S, et al. Primary leptomeningeal melanoma: an unusually aggressive tumor in childhood. Neurosurgery 1993;32:721–729

   PubMedWeb of Science
2. ↵
   Tosaka M, Tamura M, Oriuchi N, et al. Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanoma. J Neurosurg 2001;94:528–532

   CrossRefPubMedWeb of Science
3. ↵
   Aichner F, Schuler G. Primary leptomeningeal melanoma: diagnosis by ultrastructural cytology of cerebrospinal fluid and cranial computed tomography. Cancer 1982;50:1751–1756

   CrossRefPubMed
4. ↵
   Soler C, Beauchesne P, Moncet M, et al. ^99mTc-MIBI uptake in a primitive leptomeningeal melanoma. Eur J Dermatol 1998;8:169–172

   PubMed
5. ↵
   Holman BL, Wick MM, Kaplan ML, et al. The relationship of the eye uptake of N-isopropyl-p-[¹²³I]iodoamphetamine to melanin production. J Nucl Med 1984;25:315–319

   Abstract/FREE Full Text
6. ↵
   Sharp PF, Smith FW, Gemmell HG, et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986;27 ;171–177

   Abstract/FREE Full Text
7. ↵
   Neirinckx RD, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen NA. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab 1988;8[suppl]:S4–S12

   PubMed
8. ↵
   Suess E, Malessa S, Ungersböck K, et al. Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors. J Nucl Med 1991;32:1675–1681

   Abstract/FREE Full Text
9. ↵
   Ryu YH, Chung TS, Lee JD, Suh JH, Lee JT, Park CY. Detection of malignant melanoma by Tc-99m HMPAO. Clin Nucl Med 1995;20:528–530

   PubMed
10. ↵
    Coates A, Tripp E. Glutathione content of human malignant melanoma cell lines: correlation of flow cytometric and biochemical assays and application to human tumor aspilates. Melanoma Res 1992;1:327–332

    PubMed
11. ↵
    Tutus A, Erkiliç K, Ercan M, Kontas O, Aydin M, Dogan H. Scintigraphic visualization of ocular melanoma with Tc-99m glutathione. Ann Nucl Med 1997;11:143–146

    PubMed
12. ↵
    Woodruff WW, Djang WT, McLendon RE, Heinz ER, Voorhees DR. Intracerebral malignant melanoma: high-field-strength MR imaging. Radiology 1987;165:209–213

    PubMed